2 min read

UBC Announces Initiative To Accelerate COVID-19 Vaccine Real-World Evidence Generation

Learn about UBC’s vaccine-specific RWD and RWE capabilities.
Learn about UBC's vaccine-specific RWD and RWE capabilities.

As vaccine manufacturers prepare for post-authorization surveillance initiatives to generate outcome evidence in real-world settings, the ability to rapidly automate analysis of large-scale representative databases is essential.

UBC’s Executive Director, Real World Evidence, Aaron Berger comments on the dynamics at hand: “Slow and labor-intensive methods for safety and effectiveness surveillance will not suffice given the unprecedented scale and urgency this challenge demands. Modernized surveillance solutions that capitalize on interoperable health care data at scale combined with custom software solutions to automate and accelerate validated analytics are essential ingredients for successful evidence generation in this setting.”

Through the combination of real-world data, epidemiologic expertise, and proprietary automated analytics software, UBC aims to support manufacturers, regulators, and healthcare providers with the conduct of safety surveillance and outcomes research as well as vaccine comparative effectiveness research.

The real-world data analyses will be made possible through a collaboration with companies such as global healthcare technology company Cerner Corporation and its Cerner Real-World DataTM, a national, de-identified data set including approximately 92 million patients from 90 health systems.

The integration of UBC’s analytical tools and epidemiologic expertise with real-world data enables researchers to customize and automate insights from the front lines of vaccine and healthcare delivery.  This offering provides manufacturers an important option to consider for evidence generation on vaccine safety and effectiveness in the real-world setting.

Other Recent Posts

Press
3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
Press
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
Press
3 min read

UBC Recognized as a Citeline Awards Finalist Again

The Citeline Awards have recognized UBC & Seqster’s innovative collaboration as a shortlisted finalist for the Best Patient-Facing Technology Initiative Category in 2023.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.